Rockefeller Capital Management L.P. Crinetics Pharmaceuticals, Inc. Transaction History

Rockefeller Capital Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$18.11 - $22.37 $18,110 - $22,370	1,000 New	1,000 $19,000
Q1 2020 May 12, 2020	SELL	$11.52 - $26.46 $81,400 - $186,966	-7,066 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$15.24 - $25.09 $61,767 - $101,689	4,053 Added 134.52%	7,066 $177,000
Q3 2019 Nov 12, 2019	SELL	$14.91 - $25.01 $2,206 - $3,701	-148 Reduced 4.68%	3,013 $45,000
Q3 2018 Nov 02, 2018	BUY	$22.66 - $36.8 $71,628 - $116,324	3,161 New	3,161 $91,000

220

75.8M

631K

749K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.41B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.